Development, Testing, Parameterization, and Calibration of a Human Physiologically Based Pharmacokinetic Model for the Plasticizer, Hexamoll® Diisononyl-Cyclohexane-1, 2-Dicarboxylate Using in Silico, in Vitro, and Human Biomonitoring Data
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.01394
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 29, 2019
Authors
Publisher
Frontiers Media SA